130 related articles for article (PubMed ID: 38217999)
21. Metabolic Evaluation of Urine from Patients Diagnosed with High Grade (HG) Bladder Cancer by SPME-LC-MS Method.
Łuczykowski K; Warmuzińska N; Operacz S; Stryjak I; Bogusiewicz J; Jacyna J; Wawrzyniak R; Struck-Lewicka W; Markuszewski MJ; Bojko B
Molecules; 2021 Apr; 26(8):. PubMed ID: 33920347
[TBL] [Abstract][Full Text] [Related]
22. Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics.
Wei Y; Jasbi P; Shi X; Turner C; Hrovat J; Liu L; Rabena Y; Porter P; Gu H
J Proteome Res; 2021 Jun; 20(6):3124-3133. PubMed ID: 34033488
[TBL] [Abstract][Full Text] [Related]
23. Analysis of Brain Metabolites Using Two Complementary Ultrahigh-Performance Liquid Chromatography-Mass Spectrometry Methods.
Jauregui AM; Parellada SE; Neag E; Bhattacharya SK
Methods Mol Biol; 2023; 2571():133-142. PubMed ID: 36152157
[TBL] [Abstract][Full Text] [Related]
24. Bladder cancer biomarker screening based on non-targeted urine metabolomics.
Li J; Cheng B; Xie H; Zhan C; Li S; Bai P
Int Urol Nephrol; 2022 Jan; 54(1):23-29. PubMed ID: 34850327
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of bladder cancer and prediction of survival by urinary metabolomics.
Jin X; Yun SJ; Jeong P; Kim IY; Kim WJ; Park S
Oncotarget; 2014 Mar; 5(6):1635-45. PubMed ID: 24721970
[TBL] [Abstract][Full Text] [Related]
26. Serum metabolomics of laryngeal cancer based on liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
Zhang X; Hou H; Chen H; Liu Y; Wang A; Hu Q
Biomed Chromatogr; 2018 May; 32(5):e4181. PubMed ID: 29272549
[TBL] [Abstract][Full Text] [Related]
27. Counting missing values in a metabolite-intensity data set for measuring the analytical performance of a metabolomics platform.
Huan T; Li L
Anal Chem; 2015 Jan; 87(2):1306-13. PubMed ID: 25496403
[TBL] [Abstract][Full Text] [Related]
28. Targeted metabolomics in bladder cancer: From analytical methods development and validation towards application to clinical samples.
Yumba Mpanga A; Siluk D; Jacyna J; Szerkus O; Wawrzyniak R; Markuszewski M; Matuszewski M; Kaliszan R; Markuszewski MJ
Anal Chim Acta; 2018 Dec; 1037():188-199. PubMed ID: 30292293
[TBL] [Abstract][Full Text] [Related]
29. LC-MS metabolomics of urine reveals distinct profiles for non-muscle-invasive and muscle-invasive bladder cancer.
Oto J; Fernández-Pardo Á; Roca M; Plana E; Cana F; Herranz R; Pérez-Ardavín J; Vera-Donoso CD; Martínez-Sarmiento M; Medina P
World J Urol; 2022 Oct; 40(10):2387-2398. PubMed ID: 36057894
[TBL] [Abstract][Full Text] [Related]
30. Investigation of the urinary metabolic variations and the application in bladder cancer biomarker discovery.
Liu X; Cheng X; Liu X; He L; Zhang W; Wang Y; Sun W; Ji Z
Int J Cancer; 2018 Jul; 143(2):408-418. PubMed ID: 29451296
[TBL] [Abstract][Full Text] [Related]
31. Using UHPLC Q-Trap/MS as a complementary technique to in-depth mine UPLC Q-TOF/MS data for identifying modified nucleosides in urine.
Lu Z; Wang Q; Wang M; Fu S; Zhang Q; Zhang Z; Zhao H; Liu Y; Huang Z; Xie Z; Yu H; Gao X
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Apr; 1051():108-117. PubMed ID: 28340480
[TBL] [Abstract][Full Text] [Related]
32. Metabolite profiling analysis of hepatitis B virus-induced liver cirrhosis patients with minimal hepatic encephalopathy using gas chromatography-time-of-flight mass spectrometry and ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry.
Huang G; Xie S; Wang M; Mao D; Huang G; Huang J; Liu X; Zhang R; Xie J; Huang LJ; Cheng C; Yao F; Zhong Y; Lin L; Yao C
Biomed Chromatogr; 2023 Jan; 37(1):e5529. PubMed ID: 36250932
[TBL] [Abstract][Full Text] [Related]
33. LC-MS untargeted metabolomics assesses the delayed response of glufosinate treatment of transgenic glufosinate resistant (GR) buffalo grasses (Stenotaphrum secundatum L.).
Boonchaisri S; Rochfort S; Stevenson T; Dias DA
Metabolomics; 2021 Feb; 17(3):28. PubMed ID: 33609206
[TBL] [Abstract][Full Text] [Related]
34. Alternate reversed-phase and hydrophilic interaction liquid chromatography coupled with mass spectrometry for broad coverage in metabolomics analysis.
Lv W; Guo L; Zheng F; Wang Q; Wang W; Cui L; Ouyang Y; Liu X; Li E; Shi X; Xu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122266. PubMed ID: 32693368
[TBL] [Abstract][Full Text] [Related]
35. Urinary metabolomics study of vancomycin-associated nephrotoxicity based on ultra-performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry.
Cao P; Kang Y; Liu J; Liu X; Jin Y; Zhang Z
Hum Exp Toxicol; 2022; 41():9603271221119178. PubMed ID: 35984423
[TBL] [Abstract][Full Text] [Related]
36. A liquid chromatography-mass spectrometry-based metabolomics strategy to explore plant metabolic diversity.
Mori T; Rai A; Tsugawa H; Yamada Y; Saito K
Methods Enzymol; 2023; 680():247-273. PubMed ID: 36710013
[TBL] [Abstract][Full Text] [Related]
37. Dynamic urinary metabolomics analysis based on UHPLC-Q-TOF/MS to investigate the potential biomarkers of blood stasis syndrome and the effects of Danggui Sini decoction.
Huang H; Wu J; Lu R; Liu X; Chin B; Zhu H; Yin C; Cheng B; Wu Z; Chen X; Liang Y; Song H; Zheng H; Guo H; Su Z
J Pharm Biomed Anal; 2020 Feb; 179():112986. PubMed ID: 31787459
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the technical variations and the suitability of a hydrophilic interaction liquid chromatography-high resolution mass spectrometry (ZIC-pHILIC-Exactive orbitrap) for clinical urinary metabolomics study.
Zhang T; Watson DG
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():199-205. PubMed ID: 27107246
[TBL] [Abstract][Full Text] [Related]
39. Discovery and validation of bladder cancer related excreted nucleosides biomarkers by dilution approach in cell culture supernatant and urine using UHPLC-MS/MS.
Chang Q; Chen P; Yin J; Liang G; Dai Y; Guan Y; Chen Y; Zhao Y; Lu YJ; Zhang L; Song D; Yuan H
J Proteomics; 2023 Jan; 270():104737. PubMed ID: 36174950
[TBL] [Abstract][Full Text] [Related]
40. Bladder cancer determination via two urinary metabolites: a biomarker pattern approach.
Huang Z; Lin L; Gao Y; Chen Y; Yan X; Xing J; Hang W
Mol Cell Proteomics; 2011 Oct; 10(10):M111.007922. PubMed ID: 21799048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]